CryoTherapeutics SA
PrivateLast Round
Series B
Extension
Apr 2, 2024
Total Funding Raised
$47.19M
Company Overview
CryoTherapeutics SA is a medical device company developing a catheter-based cryotherapy system designed to treat atherosclerotic plaque that causes heart attacks by delivering cryoenergy to the coronary arteries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CryoTherapeutics SA Comparables
Compare CryoTherapeutics SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prescient Medical, Inc. | 79% | |
| Miracor Medical SA | 73% | |
| Corflow | 72% |
CryoTherapeutics SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 2, 2024 | ||||
| Series B | Feb 17, 2022 | ||||
| Series B | Jun 27, 2019 | ||||
| Series B | Jul 7, 2016 | ||||
| Series A Extension | May 6, 2014 | ||||
Series A | Mar 21, 2013 |
Key People
Founding team and executive leadership
CryoTherapeutics SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Series B, Series B Extension |
| Getz Brothers | Series B, Series A, Series A Extension |
| Yellowstone Holding AG | Series B, Series B Extension |
| NRW.Bank | Series A, Series B, Series B Extension, Series A Extension |
| Creathor Venture | Series B |
| GED Ventures Portugal | Series B Extension |
| Peppermint Venture Partners | Series B, Series A, Series B Extension, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2025
Launched ICECAP in partnership with SpectraWAVE and CRF.
- Nov 21, 2025
Partnered with SpectraWAVE and CRF to launch ICECAP.
Recent news
Latest coverage and updates
- is_developingSep 25, 2026
Cryotherapeutics is developing catheter-based cryotherapy system.
- is_developingJul 16, 2026
CryoTherapeutics SA is developing novel catheter-based cryotherapy system on Jul 16th '26.
CryoTherapeutics SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CryoTherapeutics SA's valuation, stock price, and market status.
Is CryoTherapeutics SA a public or private company?
CryoTherapeutics SA is a private company.
What is the current stock price of CryoTherapeutics SA?
CryoTherapeutics SA is a private company with no public stock price. No recent secondary market data is available.
How much is CryoTherapeutics SA worth (valuation)?
Valuation information for CryoTherapeutics SA is not publicly available.
Can I buy CryoTherapeutics SA stock?
CryoTherapeutics SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CryoTherapeutics SA's last funding round?
CryoTherapeutics SA's most recent funding round was Series B Extension on April 2, 2024.
Who are the main investors in CryoTherapeutics SA?
Key investors in CryoTherapeutics SA include Noshaq, Peppermint Venture Partners.
Will CryoTherapeutics SA IPO soon?
No public IPO plans have been announced for CryoTherapeutics SA.
How can I track CryoTherapeutics SA secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CryoTherapeutics SA's secondary market activity and sign up for updates.